Yucca Health Review: $125 Means $750 Up Front, Not a Month

$146 a month for compounded semaglutide and $258 for compounded tirzepatide if you pay month to month, or $750 and $1,350 in a single payment if you commit to six months — which is where the $125 and $225 in the advertising come from. Yucca states this itself in the product schema on its own pages: "Starting at $125 per month with the 6-month plan ($750 total); the month-to-month plan is $146 per month." Read on August 9, 2026 and reconciled against the product catalogue inside its intake application, which prices the same variants at $246 and $1,110 before the automatic coupon.

Because Yucca's intake applies one automatically before it shows you anything. The catalogue in its own JavaScript prices compounded semaglutide at $246 for one month and $1,110 for six, and compounded tirzepatide at $358 and $1,750. A second module holds the codes — SEMA100, SEMA270, SEMA360, TIRZ100, TIRZ270, TIRZ400 — whose trailing digits are the dollar discount, and subtracting them reproduces every advertised figure to the dollar: $246 − $100 = $146, and ($1,110 − $360) ÷ 6 = $125 on a $750 charge. The banner across the site says "Coupon Auto-Applied" and claims the six-month semaglutide rate is "$125/mo For life". Whether that survives into refills is the one thing Yucca does not publish, and its llms.txt is explicit that "pricing for refills … is disclosed during checkout".

No, and it is the best thing about the company. Yucca's FAQ: "Choose treatment & authorize payment — A temporary card hold appears but you are only charged if your provider approves your prescription." The intake repeats it on the plan card as "$0 Due Today! Only charged if prescription is approved." Most of this category takes the money at the end of the intake and offers a refund if it declines you, which means your card is exposed while somebody decides. Yucca authorises rather than captures. If a provider says no, there is nothing to claw back.

Yucca's two answers do not agree, so read the Terms rather than the plan card. The intake labels the monthly plan "Cancel Anytime" and describes it as "month-to-month with no long-term commitment". The Terms of Service say something narrower: "Subscriptions may be billed monthly, quarterly, or 6-month and automatically renew until the end of your six-month prescription." Read literally, that makes even the monthly plan a six-month course billed in instalments. What is not in dispute is what happens once an order moves: cancellation is possible before the pharmacy processes it, "may be attempted but is not guaranteed" while it is in progress, and is impossible once shipped.

Nothing is charged on top. The plan step's own heading is "Every dosage level included — no extra fees, ever", and the inclusion list is unlimited free doctor consultations, a home injection kit, free expedited shipping and 24/7 support. Two numbers in the checkout code, $150 and $39.95, look like fees and are not — they are the advertised value of the free consultations and the shipping, added into a savings display. Nothing on the site or in the checkout adds a service, platform or consultation line to the plan price.

It says all fifty, and there is no way to check. "Licensed Providers in all 50 States" runs in a bar across every page, and the Organization schema on every page says treatments are delivered "to all 50 states". But Yucca publishes no list of states, no exclusions page, and — unlike most telehealth intakes — no address gate in its sign-up application, which was searched for state tables and abbreviation arrays and contains neither. Its Terms say only that services are "available only to residents of the United States". So the claim is quotable and unverifiable in the same breath, and Washington, D.C. is not mentioned anywhere.

No. Screened on August 9, 2026 against FDA's live warning-letter index under both of the company's names and in spaced and condensed form: "yucca", "yucca health", "yuccahealth", "tryyucca", "Brand Merchants" and "Brand Merchants Network" all return zero rows. There is no near-miss to disclose and nothing has been filed on a resemblance. The two names matter because Yucca trades under both — the footers say Yucca Health, Inc. and the Terms and Refund Policy are issued by Brand Merchants Network LLC of Beverly Hills, California.

Yucca does not say, and that is the most conspicuous gap in an otherwise open company. Every reference is generic — "licensed U.S. pharmacies", "trusted pharmacy partners", "licensed compounding pharmacies" — across the FAQ, the Terms, the Shipping Policy and every product page. There is no pharmacy name, no address and no licence number anywhere on the site, so there is nothing you can look up. Compare that with the price disclosure, which is unusually specific down to a machine-readable file. A company willing to publish its prices in llms.txt could publish its pharmacies too.

Yes, and they are not on the website. Yucca's intake catalogue also carries Microdose Semaglutide+ at $199 a month, Microdose Tirzepatide+ at $249, and two oral products — SemaMelt at $279 and TirzeMelt at $349 — none of which has a product page in the sitemap, appears in llms.txt, or is reachable from the public site. They are routes the intake can offer conditionally. They are recorded here so the numbers are not a surprise mid-funnel, but they are not priced on this review because there is no public offer to hold Yucca to.